Efavirenz to Nevirapine Switch and Low-Density Lipoprotein (LDL)-Dyslipidemia
This study has been completed.
Sponsor:
University Hospital, Caen
Collaborator:
Boehringer Ingelheim Pharmaceuticals
Information provided by:
University Hospital, Caen
ClinicalTrials.gov Identifier:
NCT00405171
First received: November 27, 2006
Last updated: October 27, 2010
Last verified: October 2010
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has been completed. |
|---|---|
| Estimated Study Completion Date: | February 2006 |
| Estimated Primary Completion Date: | No date given |